KATRINA ZLATARIC: Open Payments
NPI 1407918386 · BARNHART, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 128 payments from 14 companies in 2025. Trend: 2023 $1,172 · 2024 $887 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $367 |
| ABBVIE INC. | 32 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $230 |
| Neurocrine BioSciences, Inc. | 18 | $203 |
| Axsome Therapeutics, Inc. | 6 | $160 |
| E.R. Squibb & Sons, L.L.C. | 21 | $158 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Almatica Pharma LLC | 5 | $112 |
| Vanda Pharmaceuticals Inc. | 5 | $106 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, INGREZZA, Auvelity, COBENFY, LOREEV XR, FANAPT.
Industry payments across MO — which companies pay providers there.
